Deep Dive: Can Hims Survive the GLP-1 Crackdown?
from The Rundown Hosted by Public.com
In this deep dive, Zaid breaks down how Hims became one of the hottest stocks in the market during the GLP-1 boom, and why the company suddenly found itself in the middle of an FDA crackdown and a legal fight with Novo Nordisk. He also dives into the bull case, the bear case, and whether Hims can actually build a lasting digital healthcare business from here.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Rundown?
This episode is 14 minutes long.
When was this The Rundown episode published?
This episode was published on March 14, 2026.
Can I download this The Rundown episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.